Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection
- PMID: 33180454
- DOI: 10.1021/acs.accounts.0c00413
Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection
Abstract
Understanding the interactions between nanomaterials and biological systems plays a pivotal role in enhancing the efficacy of nanomedicine and advancing the disease diagnosis. The nanoparticle-protein corona, an active biomolecular layer, is formed around nanoparticles (NPs) upon mixing with biological fluid. The surface layer which consists of rapidly exchanged biomolecules is called the "soft" corona. The inner layer which is more stable and tightly packed is called the "hard" corona. It has been suggested that the NP-protein corona has a decisive effect on the in vivo fate of nanomedicine upon intravenously administration into the mouse. Furthermore, the features of the NP-protein corona make it a powerful platform to enrich low-abundance proteins from serum/plasma for downstream mass-spectrometry (MS)-based proteomics for biomarker discovery and disease diagnosis.Herein, we summarize our recent work on the development of nanomedicine and disease detection from the level of nano-bio interactions between nanoparticles and biological systems. Nanomedicine has made substantial progress over the past two decades. However, the significant enhancement of overall patient survival by nanomedicine remains a challenge due to the lack of a deep understanding of nano-bio interactions in the clinical setting. The pharmacokinetic effect of the protein corona on PEGylated NPs during blood circulation indicated that the adsorbed apolipoproteins could prolong the circulation time of NPs. This mechanistic understanding of the protein corona (active biomolecule) formed around polymeric NPs offered insights into enhancing the efficacy of nanomedicine from the biological interactions point of view. Moreover, we discuss the basic rationale for developing bioresponsive cancer nanomedicine by exploiting the pathophysiological environment around the tumor, typically the pH, reactive oxygen species (ROS), and redox-responsive supramolecular motifs based on synthetic amphiphilic polymers. The protein corona in vivo determines the biological fate of NPs, whereas it opens a new avenue to enrich low abundant proteins in a biospecimen ex vivo to render them "visible" for downstream analytical workflows, such as MS-based proteomics. Blood serum/plasma, due to easy accessibility and great potential to uncover and monitor physiological and pathological changes in health and disease, has remained a major source of detecting protein biomarker candidates. Inspired by the features of the NP-protein corona, a Proteograph platform, which integrates multi-NP-protein coronas with MS for large-scale efficient and deep proteome profiling has been developed. Finally, we conclude this Account with a better understanding of nano-bio interactions to accelerate the nanomedicine translation and how MS-based proteomics can boost our understanding of the corona composition and facilitate the identification of disease biomarkers.
Similar articles
-
Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.Small. 2023 Jul;19(28):e2301663. doi: 10.1002/smll.202301663. Epub 2023 Apr 3. Small. 2023. PMID: 37010040 Review.
-
Enhanced Competition at the Nano-Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes.Adv Mater. 2022 Nov;34(44):e2206008. doi: 10.1002/adma.202206008. Epub 2022 Sep 20. Adv Mater. 2022. PMID: 35986672
-
How protein coronas determine the fate of engineered nanoparticles in biological environment.Arh Hig Rada Toksikol. 2017 Dec 20;68(4):245-253. doi: 10.1515/aiht-2017-68-3054. Arh Hig Rada Toksikol. 2017. PMID: 29337683 Review.
-
In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?Biotechnol Adv. 2017 Nov 15;35(7):889-904. doi: 10.1016/j.biotechadv.2017.08.003. Epub 2017 Aug 26. Biotechnol Adv. 2017. PMID: 28844973 Review.
-
In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.Acc Chem Res. 2017 Feb 21;50(2):387-395. doi: 10.1021/acs.accounts.6b00579. Epub 2017 Feb 1. Acc Chem Res. 2017. PMID: 28145686
Cited by
-
Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping.Nat Commun. 2024 Feb 2;15(1):989. doi: 10.1038/s41467-024-45233-y. Nat Commun. 2024. PMID: 38307861 Free PMC article.
-
Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy.Mater Today Bio. 2023 Dec 22;24:100926. doi: 10.1016/j.mtbio.2023.100926. eCollection 2024 Feb. Mater Today Bio. 2023. PMID: 38179429 Free PMC article. Review.
-
Bibliometric and visualized analysis of cancer nanomedicine from 2013 to 2023.Drug Deliv Transl Res. 2024 Jun;14(6):1708-1724. doi: 10.1007/s13346-023-01485-7. Epub 2023 Dec 31. Drug Deliv Transl Res. 2024. PMID: 38161193
-
Spatial tumor biopsy with fluorescence PCR microneedle array.Innovation (Camb). 2023 Nov 15;5(1):100538. doi: 10.1016/j.xinn.2023.100538. eCollection 2024 Jan 8. Innovation (Camb). 2023. PMID: 38089565 Free PMC article.
-
Biological Interaction and Imaging of Ultrasmall Gold Nanoparticles.Nanomicro Lett. 2023 Dec 4;16(1):44. doi: 10.1007/s40820-023-01266-4. Nanomicro Lett. 2023. PMID: 38047998 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous